Cargando…

Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study

BACKGROUND: Information on the influence of insulin treatment using advanced hybrid closed loop systems (AHCL) on body weight of young patients with type 1 diabetes (T1D) is scarce. The aim of this study was to observe whether there were any changes in body mass index (BMI) of children and adolescen...

Descripción completa

Detalles Bibliográficos
Autores principales: Seget, Sebastian, Jarosz-Chobot, Przemysława, Ochab, Agnieszka, Polanska, Joanna, Rusak, Ewa, Witoszek, Paulina, Chobot, Agata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592809/
https://www.ncbi.nlm.nih.gov/pubmed/36303875
http://dx.doi.org/10.3389/fendo.2022.1036808
_version_ 1784815012099915776
author Seget, Sebastian
Jarosz-Chobot, Przemysława
Ochab, Agnieszka
Polanska, Joanna
Rusak, Ewa
Witoszek, Paulina
Chobot, Agata
author_facet Seget, Sebastian
Jarosz-Chobot, Przemysława
Ochab, Agnieszka
Polanska, Joanna
Rusak, Ewa
Witoszek, Paulina
Chobot, Agata
author_sort Seget, Sebastian
collection PubMed
description BACKGROUND: Information on the influence of insulin treatment using advanced hybrid closed loop systems (AHCL) on body weight of young patients with type 1 diabetes (T1D) is scarce. The aim of this study was to observe whether there were any changes in body mass index (BMI) of children and adolescents with T1D treated using the Medtronic Minimed 780G AHCL after 1 year of follow up and to analyze potential associations between these changes and the insulin doses. MATERIALS AND METHODS: For 50 children and adolescents (age 5.4-16.8 years, 24 (48%) boys, T1D for 3.9 ± 2.56 years) using an AHCL system anthropometric and AHCL data were collected prospectively. BMI Z-scores and two-week AHCL records obtained after AHCL enrollment were compared with data after 6 months and also 1 year after starting AHCL. RESULTS: The BMI Z-score of the patients at 1 year follow-up did not change from time of AHCL initiation (0.51 ± 2.79 vs 0.57 ± 2.85, p>0.05). There was a slight increase in total daily insulin per kg of body weight (0.67 ± 0.21 U/kg vs 0.80 ± 0.21 U/kg, p <0.001), but the percent of basal insulin was unchanged (34.88 ± 6.91% vs 35.08 ± 6.30%, p>0.05). We observed also no change (AHCL start vs after 1 year) in glycemic control parameters: average sensor glucose (131.36± 11.04 mg/dL vs 132.45 ± 13.42 mg/dL, p>0.05), coefficient of variation (34.99± 5.17% vs 34.06 ± 5.38%, p>0.05), glucose management indicator (6.45 ± 0.26% vs 6.48 ± 0.32%, p>0.05), and time spent in the range of 70–180 mg/dL (79.28 ± 8.12% vs 80.40 ± 8.25%, p>0.05). CONCLUSION: During the 1 year of follow-up the BMI of children and adolescents with T1D treated with an AHCL system remained stable. Although there was a slight increase in the total daily insulin dose, the percent of basal insulin was unchanged. The patients maintained recommended glycemic control.
format Online
Article
Text
id pubmed-9592809
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95928092022-10-26 Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study Seget, Sebastian Jarosz-Chobot, Przemysława Ochab, Agnieszka Polanska, Joanna Rusak, Ewa Witoszek, Paulina Chobot, Agata Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Information on the influence of insulin treatment using advanced hybrid closed loop systems (AHCL) on body weight of young patients with type 1 diabetes (T1D) is scarce. The aim of this study was to observe whether there were any changes in body mass index (BMI) of children and adolescents with T1D treated using the Medtronic Minimed 780G AHCL after 1 year of follow up and to analyze potential associations between these changes and the insulin doses. MATERIALS AND METHODS: For 50 children and adolescents (age 5.4-16.8 years, 24 (48%) boys, T1D for 3.9 ± 2.56 years) using an AHCL system anthropometric and AHCL data were collected prospectively. BMI Z-scores and two-week AHCL records obtained after AHCL enrollment were compared with data after 6 months and also 1 year after starting AHCL. RESULTS: The BMI Z-score of the patients at 1 year follow-up did not change from time of AHCL initiation (0.51 ± 2.79 vs 0.57 ± 2.85, p>0.05). There was a slight increase in total daily insulin per kg of body weight (0.67 ± 0.21 U/kg vs 0.80 ± 0.21 U/kg, p <0.001), but the percent of basal insulin was unchanged (34.88 ± 6.91% vs 35.08 ± 6.30%, p>0.05). We observed also no change (AHCL start vs after 1 year) in glycemic control parameters: average sensor glucose (131.36± 11.04 mg/dL vs 132.45 ± 13.42 mg/dL, p>0.05), coefficient of variation (34.99± 5.17% vs 34.06 ± 5.38%, p>0.05), glucose management indicator (6.45 ± 0.26% vs 6.48 ± 0.32%, p>0.05), and time spent in the range of 70–180 mg/dL (79.28 ± 8.12% vs 80.40 ± 8.25%, p>0.05). CONCLUSION: During the 1 year of follow-up the BMI of children and adolescents with T1D treated with an AHCL system remained stable. Although there was a slight increase in the total daily insulin dose, the percent of basal insulin was unchanged. The patients maintained recommended glycemic control. Frontiers Media S.A. 2022-10-11 /pmc/articles/PMC9592809/ /pubmed/36303875 http://dx.doi.org/10.3389/fendo.2022.1036808 Text en Copyright © 2022 Seget, Jarosz-Chobot, Ochab, Polanska, Rusak, Witoszek and Chobot https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Seget, Sebastian
Jarosz-Chobot, Przemysława
Ochab, Agnieszka
Polanska, Joanna
Rusak, Ewa
Witoszek, Paulina
Chobot, Agata
Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
title Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
title_full Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
title_fullStr Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
title_full_unstemmed Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
title_short Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
title_sort body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592809/
https://www.ncbi.nlm.nih.gov/pubmed/36303875
http://dx.doi.org/10.3389/fendo.2022.1036808
work_keys_str_mv AT segetsebastian bodymassindexbasalinsulinandglycemiccontrolinchildrenwithtype1diabetestreatedwiththeadvancedhybridclosedloopsystemremainstable1yearprospectiveobservationaltwocenterstudy
AT jaroszchobotprzemysława bodymassindexbasalinsulinandglycemiccontrolinchildrenwithtype1diabetestreatedwiththeadvancedhybridclosedloopsystemremainstable1yearprospectiveobservationaltwocenterstudy
AT ochabagnieszka bodymassindexbasalinsulinandglycemiccontrolinchildrenwithtype1diabetestreatedwiththeadvancedhybridclosedloopsystemremainstable1yearprospectiveobservationaltwocenterstudy
AT polanskajoanna bodymassindexbasalinsulinandglycemiccontrolinchildrenwithtype1diabetestreatedwiththeadvancedhybridclosedloopsystemremainstable1yearprospectiveobservationaltwocenterstudy
AT rusakewa bodymassindexbasalinsulinandglycemiccontrolinchildrenwithtype1diabetestreatedwiththeadvancedhybridclosedloopsystemremainstable1yearprospectiveobservationaltwocenterstudy
AT witoszekpaulina bodymassindexbasalinsulinandglycemiccontrolinchildrenwithtype1diabetestreatedwiththeadvancedhybridclosedloopsystemremainstable1yearprospectiveobservationaltwocenterstudy
AT chobotagata bodymassindexbasalinsulinandglycemiccontrolinchildrenwithtype1diabetestreatedwiththeadvancedhybridclosedloopsystemremainstable1yearprospectiveobservationaltwocenterstudy